ArticleMolecular pharmaceutics2019

Avapritinib: A Selective Inhibitor of KIT and PDGFRα that Reverses ABCB1 and ABCG2-Mediated Multidrug Resistance in Cancer Cell Lines.

Chung-Pu Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.